US Broker Ratings

Sarepta Therapeutics (SRPT) Stock Analysis: Navigating a Challenging Biotech Landscape with a Potential Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a prominent player in the biotechnology sector, primarily focusing on revolutionary treatments for rare diseases. Specializing in RNA-targeted therapeutics and gene therapies, the company..

Vaxcyte, Inc. (PCVX) Stock Analysis: Strong Analyst Consensus and Nearly 94% Upside Potential

Vaxcyte, Inc. (NASDAQ: PCVX), a promising player in the biotechnology sector, is capturing investor attention with its ambitious pipeline of innovative vaccines aimed at combating bacterial infectious diseases. With a..

Avidity Biosciences, Inc. (RNA) Stock Analysis: A Biotech Powerhouse with 434% Revenue Growth and Promising Clinical Trials

Avidity Biosciences, Inc. (NASDAQ: RNA) stands as a promising player in the biotechnology sector, captivating investor interest with its revolutionary approach to RNA therapeutics. Notably, the company has achieved an..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 27% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) is a noteworthy player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $4.84 billion, the..

RadNet, Inc. (RDNT) Stock Analysis: A Healthcare Gem with a 25% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a leader in the healthcare diagnostics and research sector, offers a compelling opportunity for investors seeking growth in the medical imaging space. With a market capitalization..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Exploring the 3.39% Potential Upside in Biotech Innovation

For investors with an eye on the biotechnology sector, Akero Therapeutics, Inc. (NASDAQ: AKRO) stands out as a compelling prospect. With its focus on tackling serious metabolic diseases, Akero is..

Bruker Corporation (BRKR) Stock Analysis: Navigating a 7.43% Potential Upside Amidst Industry Challenges

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector specializing in medical devices, presents a fascinating investment opportunity. With a market capitalization of $7.65 billion, Bruker is a..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 22% Potential Upside for Investors

Universal Health Services, Inc. (NYSE: UHS), a cornerstone in the healthcare sector, presents an intriguing opportunity for investors looking to capitalize on the burgeoning medical care facilities industry. With a..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring Growth Potentials with Robust Buy Ratings

Revolution Medicines, Inc. (RVMD), a key player in the biotechnology sector, is making waves in precision oncology with its innovative approach to targeting RAS-addicted cancers. Headquartered in Redwood City, California,..

Exelixis, Inc. (EXEL) Stock Analysis: A Healthcare Giant with a 3.03% Upside Potential

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, has been making waves with its innovative contributions to oncology treatments. Headquartered in Alameda, California, this $11.92 billion market..

Regencell Bioscience Holdings L (RGC) Stock Analysis: What Investors Need to Know About This $15.53 Billion Market Cap Healthcare Innovator

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is capturing the attention of investors with its unique position in the healthcare sector, specifically in the specialized field of Traditional Chinese Medicine (TCM)..

BrightSpring Health Services (BTSG): Analyst Ratings Signal Strong Buy Amid 9.71% Potential Upside

BrightSpring Health Services, Inc. (BTSG), a key player in the U.S. healthcare sector, is capturing investor attention with its robust growth trajectory and favorable analyst ratings. Operating within the Health..

Bio-Techne Corp (TECH) Stock Analysis: Navigating a 2.7% Potential Upside with Strong Buy Ratings

In the dynamic world of biotechnology, Bio-Techne Corp (NASDAQ: TECH) emerges as a compelling investment with a robust market presence and a strategic focus on innovation. Headquartered in Minneapolis, Minnesota,..

Soleno Therapeutics (SLNO) Stock Analysis: Unveiling a Potential 164% Upside in the Biotech Arena

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is capturing investor attention with a compelling prospect of a 164.22% upside potential, as indicated by the average analyst target price. Positioned within the healthcare..

Chemed Corp (CHE) Stock Analysis: Exploring a 24.34% Potential Upside in the Healthcare Sector

For investors with a keen eye on the healthcare sector, Chemed Corporation (NYSE: CHE) presents a compelling opportunity. Operating primarily in the United States, Chemed delivers hospice and palliative care..

Axsome Therapeutics (AXSM) Stock Analysis: Navigating a 13% Upside Potential in the Biotech Sector

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a key player in the biotechnology sector, is making waves with its innovative approach to treating central nervous system (CNS) disorders. With a market cap..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unpacking the 32% Revenue Growth and Investor Ratings

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector, particularly within the medical devices industry, as it continues to redefine organ transplant therapies. With a market capitalization..

Qiagen N.V. (QGEN) Stock Analysis: Navigating the Diagnostics Giant’s Growth Amid Market Challenges

As investors seek promising opportunities in the healthcare sector, Qiagen N.V. (NASDAQ: QGEN) presents a compelling case with its robust market presence and innovative product offerings. Headquartered in Venlo, the..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 100.75% Potential Upside in Biotech Investment

Summit Therapeutics Inc. (NASDAQ: SMMT) is making waves in the biotechnology sector with its innovative approach to medicinal therapies. With a market capitalization of $12.28 billion, this Miami-based biopharmaceutical company..

Becton, Dickinson and Company (BDX) Stock Analysis: Navigating Growth with a 2.42% Potential Upside

Becton, Dickinson and Company (NYSE: BDX) represents a cornerstone in the healthcare sector, consistently proving its mettle in the competitive landscape of medical instruments and supplies. With a robust market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds